How do I transition a patient from Adderall XR (mixed amphetamine salts extended‑release) to Vyvanse (lisdexamfetamine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Transitioning from Adderall XR to Vyvanse

Use a 1:1 dose conversion ratio when switching from Adderall XR to Vyvanse (lisdexamfetamine), meaning 30 mg of Adderall XR converts to approximately 30 mg of Vyvanse, with the switch performed directly without a washout period.

Conversion Strategy

The conversion is straightforward based on amphetamine base equivalence:

  • Adderall XR 10 mg (6.3 mg amphetamine base) → Vyvanse 30 mg
  • Adderall XR 20 mg (12.5 mg amphetamine base) → Vyvanse 50-60 mg
  • Adderall XR 30 mg (18.8 mg amphetamine base) → Vyvanse 70 mg

This conversion is supported by the FDA labeling showing that both medications contain dextroamphetamine as the active component, though Vyvanse delivers it as a prodrug 1, 2.

Pharmacokinetic Rationale

The switch can be made immediately because:

  • Vyvanse is a prodrug that requires conversion to active d-amphetamine through red blood cell hydrolysis, resulting in a smoother pharmacokinetic profile 1
  • Time to peak effect differs: Adderall XR reaches peak at ~7 hours, while Vyvanse peaks at 3.5-4.4 hours for dextroamphetamine 1, 2
  • Half-lives are similar: Both have elimination half-lives of 9-11 hours in children and 10-13 hours in adults 1, 2
  • No washout needed: The similar half-lives and overlapping mechanisms mean you can switch the next day

Clinical Evidence for Equivalence

Direct comparison studies demonstrate comparable efficacy between these medications. In a crossover analog classroom study, both lisdexamfetamine and mixed amphetamine salts extended-release showed significant improvements in ADHD symptoms with similar adverse event profiles 3. A 2014 adult ADHD crossover trial found both medications produced significant and equal reductions in ADHD clinician ratings with response rates around 80% 4.

However, some studies suggest Vyvanse may have slight advantages: In post-hoc analysis, 32% of children were rated "very much improved" on Vyvanse versus 16% on MAS XR, a statistically significant difference 5. This may relate to Vyvanse's prodrug design providing more consistent drug delivery 6.

Practical Switching Protocol

  1. Calculate the equivalent dose using the ratios above
  2. Start Vyvanse the morning after the last Adderall XR dose
  3. Monitor for 1-2 weeks before adjusting, as the pharmacokinetic profiles differ slightly
  4. Titrate if needed: Vyvanse comes in 10 mg increments (10,20,30,40,50,60,70 mg), allowing fine-tuning 1

Important Caveats

Be prepared for tolerability differences: Research shows that 41% of medication-naive adults required switching between stimulant families (methylphenidate vs. amphetamine) due to poor tolerability within 90 days 7. While both Adderall XR and Vyvanse are amphetamine-based, individual responses vary.

Peak timing differences matter: Patients may notice Vyvanse works slightly earlier in the day (peak at 3.5-4 hours) compared to Adderall XR (peak at 7 hours) 1, 2. This can be advantageous for morning symptom control but may require adjustment of dosing time.

Food effects are minimal: Neither high-fat meals nor yogurt significantly affect Vyvanse absorption, though food delays peak by about 1 hour 1. This gives flexibility in administration.

Monitor side effects closely: Both medications share typical stimulant side effects (appetite suppression, insomnia, irritability), but the prodrug delivery of Vyvanse may reduce peak-related side effects like irritability 8, 1.

Dose Ceiling Considerations

Stay within FDA-approved ranges: For Vyvanse, the maximum approved dose is 70 mg daily 1. Recent meta-analysis data suggest that unlicensed (higher) amphetamine doses do not provide substantial additional benefit and increase adverse event dropouts 9. If 70 mg Vyvanse proves insufficient, consider alternative strategies rather than exceeding the approved dose.

References

Guideline

practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.

Journal of the American Academy of Child and Adolescent Psychiatry, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.